Our workflow takes multimodal patient data, discovers population-level subgroups, places each new patient into the nearest subgroup, and delivers interpretable decision support to the treating neurologist.
Integrating genetics, imaging, clinical assessments, molecular bio-specimens, and wearable data from diverse populations to build comprehensive disease profiles.
Generative population modeling uncovers latent biomarker associations, grouping patients into distinct mechanistic subtypes such as tremor-dominant (slow progression), PIGD (rapid progression), and cognitive-behavioral clusters.
Population-level knowledge translates into individual care, providing the neurologist with differential diagnosis support, prognostic trajectory insights, and therapeutic trial stratification.
Translational AI enables patient-level precision therapeutics and support without replacing clinical judgment, bridging the gap between large-scale population learning and individualized decision-making.
Rather than treating every Parkinson's patient identically, we use multimodal data to discover population-level subgroups: clusters of patients who share biology and disease trajectory.
When a new patient arrives, their multimodal features are projected into this population map. The system identifies the nearest subgroup and retrieves comparable patients, providing the clinician with outcome context drawn from real cases.
Imaging, wearable, clinical, and biospecimen features from the patient encounter.
The patient is mapped into a population-derived subgroup that shares biology and trajectory.
Nearest-neighbor lookup surfaces comparable cases and their longitudinal outcomes.
Monitoring priorities, pathway burden, and intervention context presented to the clinician.
Decision support dashboard concept: patient summary, subgroup classification, nearest-neighbor matches, and follow-up recommendations.
Explore the interactive workflow in the Parkinson Viz dashboard.


